Form 4 for WGS GeneDx Holdings Corp.
Accepted 2022-02-10 00:00:00 ET · period of report 2022-02-08 · accession 0001209191-22-008637 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-10 | 2022-02-08 | WGS | Ro Isaac | CFO | M - OptEx | — | +62.5K | 177.9K | +54% | — |
| D | 2022-02-10 | 2022-02-10 | WGS | Ro Isaac | CFO | S - Sale+OE | $3.60 | -21.7K | 156.2K | -12% | -$78.2K |
| D | 2022-02-10 | 2022-02-08 | WGS | Ro Isaac | CFO | M - OptEx | $0.00 | -62.5K | 750.0K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-02-08 | M | A | 62,500 | — | 177,924 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. |
| 2 | Common | Class A Common Stock | 2022-02-10 | S | D | 21,735 | $3.60 | 156,189 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.59 to $3.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |
| 3 | Derivative | Restricted Stock Unit | 2022-02-08 | M | D | 62,500 | $0.00 | 750,000 | D | — · — to — | 62,500 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F4) 1/8th of the total shares vested on October 25, 2021, 1/16th of the total shares vested on November 8, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on February 8, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date. |